Event Date:Saturday, 15th July 2017, 10:30am- 2:30 pm

Sign-up for Takeda´s IBD clinical trial advisory board (Discussion Panel)

In order to design IBD clinical trials that putpatients in the centre of our interest, Takeda Development Center Americas, Inc. and its affiliates are looking for individuals living with IBDto participate in a UK advisory board meeting.

Werecognisethat there are still many unmet needs for people who live with Inflammatory Bowel Disease(IBD). As a pharmaceutical company we believe in advancing science to help them around the world.

Our newly createdIBD clinical trialadvisory board is designed to gather direct feedback froma number of people with different experiencesand translate those into tailored and truly patient focused clinical trials in the future. Hence, we would like to learn from you. Please send an email to f you are interested in taking part inthis advisoryboard. Please note that you will be asked some questions to assess your eligibility to participate in the meeting to ensure we have diverse panelists on the day. Please note that once we have received interest froma sufficient number of applicants, we will close this request.

Your profile:You are living with IBD, residing in the UK, fulfilling below criteria

  • Diagnosed to have moderate to severe Crohn’s disease or Ulcerative Colitis
  • NOTcurrently enrolled in a clinical study, whether relating to Crohn’s disease, Ulcerative Colitis or otherwise
  • you or a member of your family DOESN’Twork for a pharmaceutical company
  • you or a member of your family is NOTa healthcare professional or a researcher in gastroenterology-related studies

Your role: During a half-day meeting we would like to learn about your IBD clinical trial motives, concerns, the endpoints you care about and desirable communication methods.

Date & time: Saturday, 15thJuly 2017, 10:30am- 2:30 pm

Venue & cost:Greater London (the location of the venue will be disclosed to selected participants only). Reasonable expenses will be reimbursed to participants based in the UK, in addition to reasonable payment made for your participation in the advisory board.

Thank you for helping advancethe scientific knowledge about IBD for all people suffering from this disease.

What’s a clinical trial? FAQs